Rifampin is a potent semi-synthetic rifamycin antibiotic primarily used for tuberculosis care. It blocks the transcription process in susceptible bacteria by binding to DNA-dependent RNA polymerase, effectively arresting bacterial growth.
Rifampin belongs to the rifamycin class of antibiotics and is known for its broad antimicrobial activity. It works primarily against certain bacteria that cause serious infections, making it a key component in multiple treatment regimens. In Singapore, the molecule appears in several pharmaceutical products that are marketed under both generic and brand names.
Rifampin is supplied in various dosage forms, most commonly as oral tablets ranging from 150 mg to 600 mg. Some preparations are designed for fixed-dose combinations with other antimicrobials, while others are single-ingredient tablets. In local pharmacies, patients may encounter it as a plain generic product or as part of a branded combination used for specific disease protocols.
These uses are guided by national treatment guidelines, and the drug is typically selected because of its ability to penetrate infected tissues and sustain bactericidal activity.
Rifampin interferes with bacterial RNA synthesis by binding to the enzyme that initiates transcription. This action blocks the production of essential proteins, ultimately leading to bacterial death. The effect is mostly bactericidal against organisms that are actively replicating, which helps reduce the bacterial load during therapy.
The tablets should be stored in a dry place away from direct sunlight and kept out of reach of children. Treatment length varies: short courses are typical for prophylaxis, while TB regimens may extend for several months. Because dosages and duration differ among the various Rifampin-containing medicines, patients should review the labeling of their individual product for exact guidance.
This article provides an educational overview of Rifampin as an active substance and does not constitute medical advice. Individual medicines containing Rifampin, such as the tablets listed under local product names, may differ in strength, formulation, and dosing instructions. The information presented here is not a substitute for professional guidance; patients should consult the labeling of their specific medication and seek guidance from a healthcare professional for any personal health decisions.